Variant report
Variant | nsv1006397 |
---|---|
Chromosome Location | chr4:60263029-60311162 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs564208665 | chr4:60266013-60266014 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs138033914 | chr4:60266018-60266019 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs540852995 | chr4:60266020-60266021 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs142525074 | chr4:60266058-60266059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs372320313 | chr4:60266063-60266064 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs116093838 | chr4:60266084-60266085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs192235957 | chr4:60266096-60266097 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs376420388 | chr4:60266107-60266108 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs551569522 | chr4:60266113-60266114 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs566650519 | chr4:60266133-60266134 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs62305701 | chr4:60266134-60266135 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs112670352 | chr4:60266147-60266148 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs184439591 | chr4:60266177-60266178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs567974244 | chr4:60266247-60266248 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs570459751 | chr4:60266254-60266255 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs371746668 | chr4:60266258-60266259 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs548005292 | chr4:60266289-60266290 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs17089646 | chr4:60266310-60266311 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs568749025 | chr4:60266327-60266328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs566161874 | chr4:60266361-60266362 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs539451140 | chr4:60266373-60266374 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs557860990 | chr4:60266376-60266377 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs572992448 | chr4:60266377-60266378 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs187530250 | chr4:60278423-60278424 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs531813850 | chr4:60278435-60278436 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs150305807 | chr4:60278475-60278476 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs573468773 | chr4:60278479-60278480 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs571860724 | chr4:60278483-60278484 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs7698051 | chr4:60278484-60278485 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
30 | rs547476347 | chr4:60278513-60278514 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs566111518 | chr4:60278522-60278523 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs137895040 | chr4:60278527-60278528 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs116193314 | chr4:60278549-60278550 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs114983535 | chr4:60278560-60278561 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs386674912 | chr4:60278564-60278565 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs17089656 | chr4:60278565-60278566 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
37 | rs140744124 | chr4:60278566-60278567 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs192004564 | chr4:60278570-60278571 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs559880810 | chr4:60278608-60278609 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs1397814 | chr4:60278609-60278610 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
41 | rs530115868 | chr4:60278643-60278644 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs79603415 | chr4:60278650-60278651 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs560673407 | chr4:60278655-60278656 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs531758129 | chr4:60278658-60278659 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs549972601 | chr4:60278666-60278667 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs184246094 | chr4:60278707-60278708 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs1397813 | chr4:60278718-60278719 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs548109383 | chr4:60278732-60278733 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs1397812 | chr4:60278734-60278735 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs569566699 | chr4:60278788-60278789 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Lung cancer | 18438408 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Prostate cancer | 16573809 | CNVD |
Osteoporosis | 18992858 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 20369283 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:60266000-60266400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr4:60278400-60278800 | Active TSS | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr4:60285400-60286000 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
4 | chr4:60285400-60286200 | ZNF genes & repeats | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
5 | chr4:60286200-60293000 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr4:60300600-60301000 | Active TSS | A549 | lung |